Concepedia

Mei-Jung Lai

ML

Statistics

Publications

22

Citations

778

H-Index

17

Active since

2010

Affiliations

Taipei Medical University(Current)

National Health Research Institutes

National Taiwan University

National Defense Medical Center

National Cheng Kung University Hospital

Mei-Jung Lai is an author at Taipei Medical University specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2010–2021

22

Publications

22

(<i>N</i>-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma <i>in Vitro</i> and <i>in Vivo</i>

Hsueh‐Yun Lee, Kunal Nepali, Fang-I Huang et al. · Journal of Medicinal Chemistry · 2018 · 80 citations · Full text

5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer’s Disease Phenotypes

Hsueh‐Yun Lee, Sheng-Jun Fan, Fang-I Huang et al. · Journal of Medicinal Chemistry · 2018 · 66 citations · Full text

Synthesis and Biological Evaluation of 1-Arylsulfonyl-5-(<i>N</i>-hydroxyacrylamide)indoles as Potent Histone Deacetylase Inhibitors with Antitumor Activity in Vivo

Mei-Jung Lai, Han-Li Huang, Shiow‐Lin Pan et al. · Journal of Medicinal Chemistry · 2012 · 59 citations · Full text

1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC

Ritu Ojha, Han-Li Huang, Wei‐Chun HuangFu et al. · European Journal of Medicinal Chemistry · 2018 · 55 citations · Full text

, , +11

Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors

Kunal Nepali, Ting-Yu Chang, Mei-Jung Lai et al. · European Journal of Medicinal Chemistry · 2020 · 49 citations · Full text

, , +8

1–5 of 22